Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor

被引:19
|
作者
Zwezerijnen, Gerben J. C. [1 ,2 ]
Eertink, Jakoba J. [2 ,3 ]
Ferrandez, Maria C. [1 ,2 ]
Wiegers, Sanne E. [1 ,2 ]
Burggraaff, Coreline N. [3 ]
Lugtenburg, Pieternella J. [4 ]
Heymans, Martijn W. [5 ,6 ]
de Vet, Henrica C. W. [5 ,6 ]
Zijlstra, Josee M. [2 ,3 ]
Boellaard, Ronald [1 ,2 ]
机构
[1] Amsterdam UMC Locat Vrije Univ Amsterdam, Radiol & Nucl Med, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Imaging & Biomarkers, Amsterdam, Netherlands
[3] Amsterdam UMC Locat Vrije Univ Amsterdam, Hematol, Amsterdam, Netherlands
[4] Univ Med Ctr, Erasmus MC Canc Inst, Hematol, Rotterdam, Netherlands
[5] Amsterdam UMC Locat Vrije Univ Amsterdam, Epidemiol & Data Sci, Boelelaan 1117, Amsterdam, Netherlands
[6] Amsterdam Publ Hlth Res Inst, Methodol, Amsterdam, Netherlands
关键词
Liver uptake; Reference; VOI; 18F]FDG PET; CT; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; METABOLIC TUMOR VOLUME; STANDARD UPTAKE VALUES; B-CELL LYMPHOMA; F-18-FDG UPTAKE; FDG UPTAKE; ONCOLOGY; BRAIN; NOISE; QUANTIFICATION;
D O I
10.1007/s00259-022-05977-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction Although visual and quantitative assessments of [18F]FDG PET/CT studies typically rely on liver uptake value as a reference or normalisation factor, consensus or consistency in measuring [18F]FDG uptake is lacking. Therefore, we evaluate the variation of several liver standardised uptake value (SUV) measurements in lymphoma [18F]FDG PET/CT studies using different uptake metrics. Methods PET/CT scans from 34 lymphoma patients were used to calculate SUVmax(liver), SUVpeak(liver) and SUVmean(liver) as a function of (1) volume-of-interest (VOI) size, (2) location, (3) imaging time point and (4) as a function of total metabolic tumour volume (MTV). The impact of reconstruction protocol on liver uptake is studied on 15 baseline lymphoma patient scans. The effect of noise on liver SUV was assessed using full and 25% count images of 15 lymphoma scans. Results Generally, SUVmax(liver) and SUVpeak(liver) were 38% and 16% higher compared to SUVmean(liver). SUVmax(liver) and SUVpeak(liver) increased up to 31% and 15% with VOI size while SUVmean(liver) remained unchanged with the lowest variability for the largest VOI size. Liver uptake metrics were not affected by VOI location. Compared to baseline, liver uptake metrics were 15-18% and 9-18% higher at interim and EoT PET, respectively. SUVliver decreased with larger total MTVs. SUVmax(liver) and SUVpeak(liver) were affected by reconstruction protocol up to 62%. SUVmax and SUVpeak moved 22% and 11% upward between full and 25% count images. Conclusion SUVmean(liver) was most robust against VOI size, location, reconstruction protocol and image noise level, and is thus the most reproducible metric for liver uptake. The commonly recommended 3 cm diameter spherical VOI-based SUVmean(liver) values were only slightly more variable than those seen with larger VOI sizes and are sufficient for SUVmean(liver) measurements in future studies.
引用
收藏
页码:486 / 493
页数:8
相关论文
共 50 条
  • [31] Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases:: preliminary results
    Travaini, Laura L.
    Trifiro, Giuseppe
    Ravasi, Laura
    Monfardini, Lorenzo
    Della Vigna, Paolo
    Bonomo, Guido
    Chiappa, Antonio
    Mallia, Andrew
    Ferrari, Mahila
    Orsi, Franco
    Paganelli, Giovanni
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (07) : 1316 - 1322
  • [32] Diagnosis of an intestinal mucormycosis 'fungus ball' located with PET/CT with [18F] FDG-PET/CT
    Gallo, Franklin
    Vija, Lavinia
    Le Grand, Sophie
    Moukarbel, Nada
    Mortele, Koen
    Gabiache, Erwan
    Courbon, Frederic
    Tavitian, Suzanne
    Dierickx, Lawrence O.
    EUROPEAN JOURNAL OF HYBRID IMAGING, 2019, 3 (01):
  • [33] [18F]FDG PET/CT versus [18F]FDG PET/MRI in the diagnosis of lymph node metastasis in nasopharyngeal carcinoma: a systematic review and meta-analysis
    Lei, Junfang
    Li, Xu
    Xue, Wenbo
    Qian, Xinrui
    Wang, Tong
    Xiang, Yunuo
    Zhang, Yangchun
    Chen, Meixing
    Liu, Zhaohui
    FRONTIERS IN MEDICINE, 2024, 11
  • [34] Reducing scan time using time-of-flight protocol in clinical [18F]FDG-PET/CT imaging: A feasibility study
    Sharifpour, Roya
    Ghafarian, Pardis
    Bakhshayesh-Karam, Mehrdad
    Uribe, Carlos F.
    Rahmim, Arman
    Ay, Mohammad Reza
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 31 (01): : 1 - 10
  • [35] The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study
    Liu, Guobing
    Li, Yanli
    Hu, Pengcheng
    Cheng, Dengfeng
    Shi, Hongcheng
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (07) : 709 - 716
  • [36] [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer
    Been, Lukas B.
    Hoekstra, Harald J.
    Suurmeijer, Albert J. H.
    Jager, Pieter L.
    van der Laan, Bernard F. A. M.
    Elsinga, Philip H.
    ORAL ONCOLOGY, 2009, 45 (12) : E211 - E215
  • [37] Semiquantitative 2-[18F]FDG PET/CT-based parameters role in lymphoma
    Albano, Domenico
    Ravanelli, Marco
    Durmo, Rexhep
    Versari, Annibale
    Filice, Angelina
    Rizzo, Alessio
    Racca, Manuela
    Pizzuto, Daniele Antonio
    Bertagna, Francesco
    Annunziata, Salvatore
    FRONTIERS IN MEDICINE, 2024, 11
  • [38] Robustness of [18F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity
    Palomino-Fernandez, David
    Seiffert, Alexander P.
    Gomez-Grande, Adolfo
    Lopez-Guarch, Carmen Jimenez
    Moreno, Guillermo
    Bueno, Hector
    Gomez, Enrique J.
    Sanchez-Gonzalez, Patricia
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2024, 244
  • [39] [18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT
    Mu, Xingyu
    Huang, Xiaoxue
    Jiang, Zewen
    Li, Meng
    Jia, Lulu
    Lv, Zhongyuan
    Fu, Wei
    Mao, Jingsong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1205 - 1215
  • [40] Relationship between [18F]FDG PET/CT and metabolomics in patients with colorectal cancer
    Imajo, Masashi
    Norikane, Takashi
    Yamamoto, Yuka
    Maeda, Yukito
    Saitoh, Kaori
    Kato, Keiko
    Soga, Tomoyoshi
    Okano, Keiichi
    Nishiyama, Yoshihiro
    METABOLOMICS, 2022, 18 (11)